Construction And Real Estate Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ginkgo Biloba Leaf Dry Extract, (Obg) Atc N06dp01 for the Period January 1St, 2025 - December 31St, 2026

Open House Drug Discount Contracts Lipegfilgrastim, Atc L03aa14

Open House Originals Discount Agreements 2024-12 - Tofacitinib

Open House Originals Discount Agreements 2024-14 - Bimatoprost / Timolol (Dosage Form: Eye Drops as Single-Dose Pipettes)

Open House Biologics Discount Agreements 2024-12 - Dornase Alfa

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Rotigotine, (Obg) Atc N04bc09 for the Period January 1St, 2025 - December 31St, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pyridostigmine (Excluding Retarded Dafo.), (Obg) Atc N07aa02 for the Period January 1St, 2025 - December 31St, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Clindamycin + Benzoyl Peroxide, (Obg) Atc D10af54 for the Period January 1St, 2025 - December 31St, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V on Active Ingredients (Medicines) - Vv 80

Open House Drug Discount Agreements Tocilizumab, Atc L04ac07